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Impaired cardiovascular autonomic nervous system (ANS) function has been reported in
type 1 diabetes (T1D) patients. ANS function, evaluated by heart rate variability (HRV),
systolic blood pressure variability (SBPV), and baroreflex sensitivity (BRS), has been linked
to aerobic capacity (VO2peak) in healthy subjects, but this relationship is unknown in T1D.
We examined cardiovascular ANS function at rest and during function tests, and its rela-
tions to VO2peak in T1D individuals. Ten T1D patients (34±7 years) and 11 healthy control
(CON; 31±6 years) age and leisure-time physical activity-matched men were studied. ANS
function was recorded at rest and during active standing and handgrip. Determination of
VO2peak was obtained with a graded cycle ergometer test. During ANS recordings SBPV,
BRS, and resting HRV did not differ between groups, but alpha1 responses to maneuvers
in detrended fluctuation analyses were smaller in T1D (active standing; 32%, handgrip;
20%, medians) than in CON (active standing; 71%, handgrip; 54%, p<0.05). VO2peak was
lower in T1D (36±4 ml kg−1 min−1) than in CON (45±9 ml kg−1 min−1, p<0.05). Resting
HRV measures, RMSSD, HF, and SD1 correlated with VO2peak in CON (p< 0.05) and when
analyzing groups together.These results suggest thatT1D had lower VO2peak, weaker HRV
response to maneuvers, but not impaired cardiovascular ANS function at rest compared
with CON. Resting parasympathetic cardiac activity correlated with VO2peak in CON but not
in T1D. Detrended fluctuation analysis could be a sensitive detector of changes in cardiac
ANS function in T1D.
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INTRODUCTION
The autonomic nervous system (ANS) is a major regulator of the
cardiovascular system. It regulates heart rate and blood pressure in
the short-term to cope with everyday situations. Parasympathetic
(vagal) modulation decreases the heart rate and cardiac contrac-
tility, whereas activity of the sympathetic branch opposes these
effects and regulates peripheral vasoconstriction.
Balanced cardiac ANS function is based on strong parasympa-
thetic and efficient, but not overactive, sympathetic modulation of
the heart. Efficient ANS function has been associated with lower
risk of cardiovascular complications (Huikuri et al., 2000). The
relationships between aerobic exercise training or high aerobic
capacity and enhanced vagal modulation of the heart have been
widely reported, especially in healthy populations (Billman, 2002;
Buch et al., 2002; Carter et al., 2003; Hautala et al., 2009). Also
the relation between exercise and decreased sympathetic activity
has been suggested (Billman, 2002). Impaired cardiovascular ANS
function has been associated with type 1 diabetes (T1D) (Ziegler
et al., 2001; Riihimaa et al., 2002; Dalla Pozza et al., 2007; Lucini
et al., 2009; Rosengård-Bärlund et al., 2009; Spallone et al., 2011;
Kuehl and Stevens, 2012). Recently, we reported lower aerobic
capacity (VO2peak) in Type 1 diabetes patients than in healthy
controls (Peltonen et al., 2012), which is in agreement with sev-
eral other papers (Niranjan et al., 1997; Komatsu et al., 2005; Gusso
et al., 2008; Nadeau et al., 2010). However, the associations between
ANS function and aerobic capacity are not as well known in T1D
than in several other populations.
Impaired cardiovascular ANS function (Manzella and Paolisso,
2005; Carnethon and Craft, 2008) and lower aerobic capacity
(Albright et al., 2000) are often related also to type 2 diabetes. The
suggested possibly mechanisms to diabetic autonomic dysfunction
include hyperglycemia induced ANS damages and effects of hyper-
insulinemia due to insulin resistance (Manzella and Paolisso, 2005;
Carnethon and Craft, 2008). T1D is caused by a relative or absolute
deficiency of insulin secretion, but type 2 diabetes is mainly char-
acterized as an insulin resistance state. Although this division is
not strict, as insulin resistance can also exist in T1D and insulin
deficiency in type 2 diabetes, the etiology of the diseases differs
greatly. In addition, physical activity has been inversely associated
with onset of type 2 diabetes also independently of weight loss
(Bassuk and Manson, 2005; Carnethon and Craft, 2008). This may
be due to improved insulin sensitivity or effects on ANS func-
tion, or both. In addition, exercise training has also been related
to improved cardiovascular ANS function in patients who already
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have caught type 2 diabetes (Loimaala et al., 2003; Pagkalos et al.,
2008). Similar associations between exercise, cardiovascular ANS
function, and disease itself are not as well known in T1D, and they
cannot be generalized between type 1 and type 2 diabetes. The
further knowledge of these relations is needed, when planning
and developing the exercise training instructions and treatment
recommendations to T1D patients.
Quantification of cardiovascular ANS function has widely been
performed with supine rest recording and with deep breathing,
active standing, and handgrip tests (Ewing et al., 1985). Combined
with the sophisticated modern analyses of heart rate variability
(HRV), systolic blood pressure variability (SBPV), and baroreflex
sensitivity (BRS), changes in cardiovascular ANS function of T1D
patients can be detected before any manifestation of clinical neu-
ropathy symptoms (Task Force of ESC and NASPE, 1996; Weston
et al., 1996, 1998; Ziegler et al., 2001; Spallone et al., 2011; Kuehl
and Stevens, 2012). Accordingly, T1D-related changes in cardio-
vascular ANS function have been reported in adults (Weston et al.,
1996, 1998; Ziegler et al., 2001; Rosengård-Bärlund et al., 2009),
as well as in adolescents and children (Riihimaa et al., 2002; Dalla
Pozza et al., 2007; Lucini et al., 2009). In addition, the studies are
diverse concerning maneuvers and ANS variables. In some stud-
ies, cardiovascular ANS function changes in T1D patients were
found in supine (Weston et al., 1998; Dalla Pozza et al., 2007;
Lucini et al., 2009), but in others only in active standing (Ziegler
et al., 2001; Riihimaa et al., 2002). The greatest impairments in
T1D patients often have existed in BRS and SBPV (Ziegler et al.,
2001; Dalla Pozza et al., 2007; Lucini et al., 2009). However, these
previous studies do not contain data on aerobic capacity of the
subjects. In addition, at least to our knowledge, detrended fluc-
tuation analyses have not been reported in T1D patients. This
non-linear HRV method reflects different phenomena than widely
used time and frequency domain HRV methods (Peng et al.,
1995).
The aim of this study was to examine if cardiovascular ANS
function supine at rest and during deep breathing, active stand-
ing, and handgrip tests was related to T1D and to lower aerobic
capacity in T1D patients than in healthy controls. In addition, we
aimed at versatile profiling of cardiac ANS function differences
between T1D patients and healthy controls (CON) by analyzing
HRV by time domain, frequency domain, and non-linear meth-
ods. Our hypotheses were that cardiovascular ANS function would
be altered in T1D patients relative to healthy and that non-linear
methods might be sensitive to indicate these changes. In addition,
we hypothesized that VO2peak would associate with cardiovascular
ANS function in T1D patients.
MATERIALS AND METHODS
SUBJECTS
Study subjects comprised 10 T1D patients and 11 CON. From
these, nine T1D and nine CON were the same subjects as in
our recent paper (Peltonen et al., 2012). All were non-smoking
men without diagnosed cardiovascular, renal or psychiatric dis-
eases, high blood pressure, abundant ectopic heart beats, or regular
medication, except for insulin in T1D. The study groups did not
differ in age or anthropometric data, and were matched by their
leisure-time physical activity (LTPA; Table 1).
Table 1 | Characteristics of the study population and results.
Characteristic Type 1 diabetes
patients
Controls
n 10 11
Age (years) 34±7 31±6
Duration of type 1 diabetes 11±6 −
HbA1c (%) 7.7±0.9† −
Height (cm) 177.8±8.8 183.7±5.4
Weight (kg) 77.0±11.5 85.1±10.7
BMI (kg/m2) 24.4±3.1 25.2±3.3
Body fat (%) 15.5±5.3 17.2±8.3
LTPA (min/week) 289±155 352±156
VO2peak (ml kg−1 min−1) 36±4* 45±9
HRmax (bpm) 180±9 184±14
30/15 ratio 1.61±0.32 1.41±0.30
max/min RRIs 1.28±0.11† 1.32±0.16
Values are means±SD. HbA1c, glycosylated hemoglobin; BMI, body mass index;
LTPA, leisure-time physical activity; HRmax, maximum heart rate during exercise;
bpm, beats per minute; 30/15 ratio, lying to standing heart rate response; max/min
RRIs, maximum to minimum ratio of RRIs in deep breathing test. *Difference
between groups; p<0.05; †n=9.
EXPERIMENTAL DESIGN
The protocol was in accordance with the Declaration of Helsinki
and was approved by the Ethics Committee of the Hospital District
of Helsinki. All subjects gave written informed consent. The aer-
obic capacity measurement and body composition analysis were
performed on the subjects’ first visit to the laboratory and the car-
diovascular ANS function testing on the second, so that subjects
were familiar with a face mask for respiration frequency measure-
ments before ANS function recordings. HbA1C was analyzed from
venous blood samples of T1D. Subjects answered written ques-
tions about LTPA. Subjects were asked to abstain from alcohol and
vigorous exercise for 24 h and caffeine for 12 h before testing.
AEROBIC CAPACITY MEASUREMENT AND BODY COMPOSITION
ANALYSIS
Body composition analysis was performed by using a bioimped-
ance method (Inbody 720, Biospace Co., Ltd., Seoul, South-Korea),
and body mass index (BMI) was calculated. Before the cycle
ergometer test, the physician evaluated the suitability of sub-
jects for the maximal exercise test. Glucose concentration from
a fingertip blood sample was controlled to be in the range of 5.6–
16.7 mmol/l before and 10 min after the exercise test. The patients
injected the insulin that they routinely use or used oral glucose
supplementation if needed. The graded cycle ergometer test was
preceded by a 6-min resting period with the subject sitting on the
cycle ergometer and then a 5-min unloaded cycling period. The test
protocol consisted of 40 W increments every 3 min until the sub-
ject’s voluntary fatigue. Ventilation and alveolar gas exchange were
measured breath-by-breath by a low-resistance turbine (Triple V,
Jaeger Mijnhardt, Bunnik, Netherlands) and a mass spectrometer
(AMIS 2000, Innovision, Odense, Denmark). To obtain VO2peak
values, gas delay determinations were performed to measured raw
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breath-by-breath data, and then alveolar gas exchange was calcu-
lated with the slightly modified algorithms of Beaver et al. (1981).
Moving averages of individual test data were calculated over 5 s
periods to reduce breath-by-breath variability, and interpolated to
obtain values second by second, after which a VO2peak value was
determined as the highest value of a 60-s moving average window.
AUTONOMIC NERVOUS SYSTEM FUNCTION MEASUREMENTS
Autonomic nervous system function testing was performed in a
quiet, dimly lit laboratory between 08:00 and 13:00 hours. The
ANS function test battery included four different 5-min tests:
(1) resting, (2) deep breathing (3 min× 1 min with the breath-
ing frequency of 6/min), (3) active standing, and (4) handgrip,
all of which were preceded by 5-min rest periods. Resting, deep
breathing, and handgrip tests were performed while subjects were
in a supine position. The subjects maintained a sustained hand-
grip with a hydraulic hand dynamometer (Baseline, Fabrication
Enterprises, Inc., New York, NY, USA) at 30% of their maximum
voluntary contraction, which was measured before the ANS func-
tion recording protocol. The subjects performed handgrip test
with a 90˚ angle in their right elbow joint, and the arm was sup-
ported by a pillow. They received verbal instructions to hold right
grip strength and saw the strength indicator of a dynamometer
via a mirror. The handgrip test was terminated if the subject was
unable to maintain the required force of contraction and fatigued
before the 5-min mark.
Continuous beat-by-beat blood pressure from a left middle
finger was recorded via plethysmography (Nexfin, Bmeye, Ams-
terdam, Netherlands). In addition, the signal of respiratory flow
from a low-resistance turbine and a mass spectrometer together
with a standard II-lead ECG signal were collected by a Power-
lab data acquisition system (Powerlab, ADInstruments, Sydney,
Australia) with a sampling frequency of 1,000 Hz.
SIGNAL ANALYSES
Baroreflex sensitivity and time and frequency domain analyses
of HRV and SBPV were performed with Barox (Oulu, Finland)
and Powerlab 5.0 software, and non-linear HRV analyses with
Kubios 2.0 software (Kuopio, Finland). Data were resampled at
2 Hz (Task Force of ESC and NASPE, 1996). ECG and blood pres-
sure recordings were inspected visually, and the recordings with
poor quality were excluded from the analyses. Some of the blood
pressure recordings included automatic signal calibration during
two or three heartbeats every 70th beat. These periods were inter-
polated based on three previous beats, as were done with ectopic
heartbeats in ECG and blood pressure signals. Analyses were per-
formed during the last 2 min of resting periods, active standing,
and handgrip tests, to obtain the effects of each maneuver and
during comparable time periods.
Spectral HRV, SBPV, and BRS parameters were analyzed as a
low frequency (LF) component (0.04–0.15 Hz). The LF compo-
nent of HRV reflects parasympathetic and sympathetic cardiac
ANS modulation and is related to arterial blood pressure control
(Task Force of ESC and NASPE, 1996). HRV was analyzed also as
a high frequency (HF) component (0.15–0.4 Hz), which is consid-
ered to be an estimate of parasympathetic ANS activity based on
mainly sinus arrhythmia (Task Force of ESC and NASPE, 1996).
Spectral methods were performed with an autoregressive model
(Burg’s algorithm), and the model order was determined by the
Akaike information criterion. BRS was investigated by frequency
domain analyses of SBPV and concomitant variability of heart rate
using an alpha method (Pagani et al., 1988). BRS analyses with a
coherence criterion of at least 0.5 were accepted. In addition, HRV
time domain parameters, the square root of the mean of the sum
of the squares of differences between adjacent RRIs (RMSSD) for
parasympathetic activity and standard deviation of RRIs (SDNN)
for total HRV were analyzed (Task Force of ESC and NASPE, 1996).
Also non-linear HRV analyses of Poincaré plot and detrended
fluctuation analysis were performed. SD1 of Poincaré plot repre-
sents the standard deviation of the short-term RR interval vari-
ability origin from cardiac parasympathetic regulation (Brennan
et al., 2001). Detrended fluctuation analysis and its parameter frac-
tal scaling exponent alpha1 describes the short-term, in this study
4–11 beats, fractal correlation properties within the RRI data (Peng
et al., 1995; Tulppo et al., 2001). Changes in alpha1 have been cor-
related with changes in the LF:HF ratio related to ANS function
tests (Tulppo et al., 2005).
The 30/15 ratio of active standing was calculated as the ratio
between the longest and the shortest RRI after standing up (Ewing
et al., 1985). Maximum to minimum ratio of RRI (max/min RRI)
during the breathing cycle was calculated as a mean of 12 cycles
(four of each min). The “delta” values of variables were calculated
by taking the value during the last 2 min of active standing or
the handgrip test and subtracting the value during the preceding
2-min resting period. The percentage change caused by the maneu-
ver was calculated by the delta value and by the non-transformed
value of the preceding rest period.
STATISTICS
Data were analyzed by PASW Statistics 17 (SPSS, Chicago, IL,
USA). The normal distribution of the variables was tested by the
Shapiro–Wilk goodness-of-fit test. Non-parametric statistics were
used because of several non-Gaussian distributed variables. Dif-
ferences between T1D and CON in analyzed variables were tested
by using Mann–Whitney U -test. The effect of a maneuver was
tested by comparing the value of the maneuver to the correspond-
ing value of the preceding rest period by Wilcoxon signed-rank
test. Correlations were tested by Spearman’s correlation. Signifi-
cance was defined as p< 0.05. The results are presented as medians
(interquartile range), if not indicated as means± SD.
RESULTS
Type 1 diabetes patients had lower VO2peak than CON, although
the groups were matched by the amount of self-reported LTPA
(Table 1). Aerobic capacity correlated with LTPA in CON (r = 0.66,
p= 0.03), but not in T1D (r =−0.38, p= 0.28). Heart rate, blood
pressure, breathing frequency, and time and frequency domain
analyses of HRV and BRS did not differ between T1D and CON at
rest or during active standing or the handgrip test (Tables 2 and 3).
Absolute and percentage changes of ANS measures related to
the maneuvers were also similar in both groups. LF variability
of systolic blood pressure at rest was 8.7 (8.7) mmHg2 in T1D
and 17.8 (13.0) mmHg2 in CON and failed to differ significantly
between the groups (p= 0.06). During active standing, LF of SBPV
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Table 2 | Values of autonomic nervous system function variables at rest and changes in active standing and in the handgrip test compared with
preceding rest period inT1D (type 1 diabetes patients) and CON (healthy controls).
Rest ∆Active standing ∆Handgrip
T1D CON T1D CON T1D CON
Heart rate (bpm) 59 (12) 58 (16) +20* (13) +26* (16) +22* (16)‡ +27* (21)†
Breathing frequency (Hz) 0.19 (0.12)
‡
0.20 (0.18) +0.03* (0.03)‡ 0.00 (0.08) +0.08* (0.08)‡ +0.05*(0.11)
Blood pressure
Systolic (mmHg) 118 (18) 121 (22) +4.4 (11) −5.0 (24) +40* (20)§ +41* (23)
Diastolic (mmHg) 66 (8) 65 (7) +11* (9) +7.6* (12) +26* (16)§ +29* (9)
Values are medians (interquartile ranges).*Significant difference between the value of the last 2 min of the maneuver and that of the last 2 min of the preceding rest
period within the group (p<0.05). †n=10 (CON); ‡n=9; §n= 8.
Table 3 | Values of heart rate variability measures and baroreflex sensitivity at rest and percentage changes in active standing and in the
handgrip test compared with the preceding rest period inT1D (type 1 diabetes patients) and CON (healthy controls).
Rest Change in standing Change in handgrip
T1D CON T1D CON T1D CON
SDNN (ms) 61 (38) 77 (49) −6% (43) −16%† (48) −6% (54) −24%† (65)‡
RMSSD (ms) 42 (27) 69 (57) −46%† (32) −32%† (72) −58%† (44)§ −65%† (29)‡
HF (ms2) 622 (1460) 1161 (1167) −60%† (64) −85%† (77)‡ −74%† (39)§ −81%† (32)‡
LF (ms2) 1820 (3417) 858 (3213)
‡ −3% (67)§ +19% (141) −81%† (41)§ −82%† (49)‡
LF:HF 2.5 (4.4) 2.1 (3.5)
‡
+227%
†
(575)§ +415%
†
(1490)
‡
+35% (267)§ +91% (276)§
DFA: alpha1 1.2 (0.6) 1.0 (0.4)
‡
+32%*
†
(39) +71%
†
(80) +20%* (48) +54%
†
(69)
‡
Poincaré: SD1 (ms) 30 (19) 42 (34)
‡ −46%† (32) −63%† (42) −48%† (41) −66%† (37)‡
Baroreflex sensitivity
LF (ms/mmHg) 14 (11) 15 (12)§ −63%† (32)§ −53%† (62) −65%† (44)¶ −70%† (33)‖
Values are medians (interquartile ranges). RRI, RR interval; SDNN, SD of RRIs; RMSSD, square root of the mean of the sum of the squares of differences between
adjacent RRIs; HF, high frequency; LF, low frequency; DFA, detrended fluctuation analysis; SD1, SD of the short-term RR interval variability. *Significant difference
between the groups (p<0.05); †significant difference between the value of the last 2 min of the maneuver and that of the last 2 min of the preceding rest period
within the group (p<0.05); ‡n=10 (CON); §n=9; ‖n=8; ¶n=7.
increased in T1D [586 (744)%, n= 9] and in CON [123 (441)%,
n= 11], but not during the handgrip test [T1D: 37 (130)%, n= 9;
CON: 96 (211)%,n= 11] and no group differences were seen. Nor
did the groups differ in 30/15 ratio of active standing or maximum
to minimum ratio of deep breathing (Table 1).
The HRV measure of SD1 did not differ between T1D and
CON. However, the percentage changes related to active stand-
ing and the handgrip test in the detrended fluctuation analysis
variable alpha1 were smaller in T1D than in CON (Table 3;
Figure 1). Because of the differences between T1D and CON
in alpha1 responses to the maneuvers, the correlation between
percentage alpha1 changes and VO2peak was also tested. The per-
centage changes of alpha1 related to the handgrip test corre-
lated with VO2peak in CON and when the groups were analyzed
together (r = 0.76, p= 0.01 and r = 0.66, p= 0.02, respectively),
but not in T1D (r = 0.08, p= 0.83). The changes related to
active standing did not correlate with VO2peak (T1D: r =−0.30,
p= 0.93; CON: r = 0.47, p= 0.14, and groups together: r = 0.44,
p= 0.05).
The HRV measures RMSSD, HF, and SD1 at rest correlated
with VO2peak when the groups were analyzed together (Figure 2).
The correlations remained in CON (r = 0.77, 0.66, and 0.73,
respectively, all p< 0.05), but not in T1D (r = 0.53, 0.36, and 0.54,
all p> 0.05). In addition, maximum to minimum ratio of deep
breathing correlated to VO2peak in CON (r = 0.77, p= 0.01), but
not in T1D (r = 0.45, p= 0.22).
DISCUSSION
The main finding of this study was that T1D patients had
smaller changes in non-linear detrended fluctuation analyses dur-
ing active standing and handgrip than CON (Figure 1). Fur-
thermore, in CON but not in T1D, lower VO2peak was associ-
ated with lower parasympathetic cardiac activity at rest, evalu-
ated by the HRV measures HF component, RMSSD, and SD1
(Figure 2).
Previous data have suggested functional impairment in both
parasympathetic and sympathetic branches of cardiovascular ANS
in T1D compared with healthy controls (Weston et al., 1998;
Ziegler et al., 2001; Riihimaa et al., 2002; Vinik et al., 2003; Dalla
Pozza et al., 2007; Lucini et al., 2009; Rosengård-Bärlund et al.,
2009). Some studies have shown the impairments only in resting
HRV, but not in the responses to active standing or the handgrip
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FIGURE 1 | Alpha1 values at rest and in active standing (A) and at rest
and in the handgrip test (B) in type 1 diabetes patients (T1D) and in
healthy controls (CON). Medians and quartiles 1 and 3. For the sake of
clarity, only one other quartile is visible. n=10 (T1D) and 11 (CON) in active
standing and n=10 (T1D) and n=10 (CON) in the handgrip test.
test (Lucini et al., 2009; Rosengård-Bärlund et al., 2009). We found
tendencies of lower HRV median values of RMSSD, HF, and SD1
at rest in T1D compared with CON (Table 3). We did not observe
differences in SBPV or BRS between T1D and CON at rest or dur-
ing active standing and handgrip. However, relatively high inter-
and intra-individual variability of ANS measures, together with
our fairly small sample size, weakened statistical power of our
results. Our T1D represented a stage of T1D where they were
free of diabetes-related chronic diseases, such as cardiovascular or
renal diseases, which are usually linked to T1D. This could be due
to the modern efficient diagnosis and treatment of T1D, which
nowadays offer good possibilities for maintaining the disease in
balance, thus reducing the risks of T1D -related complications,
such as impairment of ANS function.
In addition, we found differences in ANS maneuvers with non-
linear detrended fluctuation analyses, as the changes of alpha1 with
active standing and handgrip test were smaller in T1D than in CON
(Table 3; Figure 1). Physiological background of non-linear HRV
measures is not yet as well known as it is for time and frequency
domain variables. Changes in alpha1 correlated with changes in
the LF:HF ratio related to ANS function tests (Tulppo et al., 2001,
2005). In line with this, our results of alpha1 and LF:HF at rest and
their changes related to the maneuvers were parallel (Table 3). In
addition, although LF:HF changes were not significant, the median
values of these changes in CON were almost twofold to those in
T1D (Table 3). Alpha1 changes during active standing and in the
handgrip test reflected increased cardiac sympathetic activity and
a concomitant decrease in parasympathetic cardiac modulation.
Tendencies of minor changes in alpha1 values with the maneuvers
(Table 3; Figure 1) could indicate that T1D have attenuated cardiac
sympathetic responsiveness compared with CON. Thus, although
further studies are needed, non-linear HRV methods seemed to
be more sensitive to detecting changes in the function of cardiac
ANS related to T1D than time and frequency domain analyses.
In addition, our results indicate that alongside the recordings at
rest, HRV should be analyzed from recordings during maneuvers,
because responsiveness is essential in managing the challenges of
normal daily life.
FIGURE 2 | Correlations between VO2peak and square root of the mean
of the sum of the squares of differences between adjacent RRIs
(RMSSD) (A); high frequency component of HRV (B); and Poincaré plot
variable SD1 (SD of the short-term RR interval variability) (C) at rest in
type 1 diabetes patients (T1D) and in healthy controls (CON).
Spearman correlation coefficients and p-values of the groups analyzed
together. n=10 (T1D) and n=11 (CON).
Respiration frequency below 0.15 Hz confounds frequency
domain analyses. In these cases, the respiration component
of HRV may be partly or completely in the frequency area
of the LF component. Although respiration frequency did
not differ between T1D and CON, we removed the possi-
ble effect of slow breathing on spectral analyses by a least-
means-square-based adaptive filter (Tiinanen et al., 2009). The
results are not shown because the group differences in val-
ues of LF variables were similar when the data were ana-
lyzed with or without the adaptive filter, indicating that there
were no significant effects of breathing frequency on the
results.
Some (Niranjan et al., 1997; Komatsu et al., 2005; Gusso
et al., 2008; Nadeau et al., 2010), but not all (Veves et al.,
1997; Benbassat et al., 2001), studies indicate that T1D patients
have lower VO2peak or VO2max than healthy controls. Accord-
ingly, we recently reported lower VO2peak in T1D than in CON,
despite the groups were matched based on the amount of self-
reported LTPA (Peltonen et al., 2012). In case of diabetic ANS
dysfunction developed to a severe neuropathy, autonomic reg-
ulation of blood pressure, and heart rate during exercise could
be impaired. In the present study, however, ANS function did
not indicate neuropathy in T1D (Ewing et al., 1985). In addi-
tion, we recently reported similar blood pressure responses during
the graded exercise test in T1D and in CON (Peltonen et al.,
2012). Although beyond the scope of this study, the reasons
for limited VO2peak in T1D could be various and complicated,
and they are not necessarily directly related to ANS function.
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Glycemic balance is known to affect VO2peak, but its mecha-
nisms are not well known (Baldi and Hofman, 2010). Recently,
we reported well-maintained arterial oxygen saturation in T1D
during peak exercise, suggesting normal alveolar gas transfer (Pel-
tonen et al., 2012). We also reported similar tissue deoxygenation
in T1D and CON at peak exercise, suggesting similar mismatch
between oxygen delivery and its utilization in the both study
groups.
Aerobic capacity may be limited due to reduced stroke vol-
ume (Gusso et al., 2008), which in T1D is often due to dias-
tolic dysfunction (Baldi and Hofman, 2010). Accordingly, car-
diac structural and/or functional alterations possibly resulting
diastolic dysfunction often exist in T1D patients, even in chil-
dren and adolescents (Carugo et al., 2001; Nadeau et al., 2010;
Nadeau and Reusch, 2011). Interestingly, in both type 2 dia-
betes (Poirier et al., 2003) and in T1D (Karamitsos et al., 2008),
diastolic dysfunction has been related to cardiovascular ANS
function. The mechanisms of these associations are unknown.
Poirier et al. (2003) discuss that, because cardiac ANS is one
regulator of myocytes’ calcium handling, could altered cardiac
ANS function be a mediator of left ventricular dysfunction.
The causal relation remains, however, unclear. Unfortunately,
we were unable to measure cardiac left ventricular function.
We recently reported, however, that earlier tissue deoxygena-
tion in T1D than in CON during the graded exercise test
along with lower VO2peak suggest restrictions of cardiac out-
put and/or peripheral vascular function in T1D (Peltonen et al.,
2012).
In healthy populations, the association between enhanced vagal
cardiac modulation and higher aerobic capacity is possibly linked
with exercise training adaptations of the heart, such as decreased
cardiac work load and oxygen demand. In the review of Hautala
et al. (2009), they suggest that stronger cardiac vagal modula-
tion could be one of the possibly mechanisms for greater train-
ing effect on VO2max or VO2peak, and may partly explain the
wide interindividual variation of training adaptation in healthy
population. In our study, LTPA did not correlate with VO2peak
in T1D, but we found that association in CON. In addition,
although not significantly, we found tendencies of lower HRV
median values of RMSSD, HF, and SD1 at rest in T1D com-
pared with CON (Table 3). The majority of these parasympathetic
HRV values of T1D were situated in the lower half of the cor-
relation plot of HRV and VO2peak, similar to CON with low
VO2peak (Figure 2). Interestingly the association between cardiac
parasympathetic ANS function and VO2peak was not similar in
T1D and in CON. Higher parasympathetic cardiac ANS func-
tion at rest was associated with higher VO2peak in CON but not
in T1D (Figure 2). Also RRI response to deep breathing test
did not correlate significantly with VO2peak in T1D, although
significant correlation existed in CON. The relative narrow dis-
tribution of VO2peak in T1D may mask the phenomenon in these
patients.
In the discussion of training adaptation, certain effects of
training dose-response relationship on the interindividual vari-
ation of training adaptation should be also taken in to account.
The dose-response relationships of training with, both aerobic
capacity and ANS function are not known in T1D. The mode
of training, duration, and intensity of individual exercise session,
as well as training frequency and duration of training history,
are known to effect on these responses in healthy populations
(Uusitalo et al., 2002; Hautala et al., 2009). In addition, because
of subjective nature of LTPA questionnare form, we cannot rule
out the possibility of reporting bias. T1D patients might benefit
from exercise training due to improvements in their cardiovas-
cular ANS function, even in cases when their VO2peak would not
change significally.
Knowledge of the associations between aerobic capacity, train-
ing, and ANS function in T1D is essential. T1D is related
to increased risk of cardiovascular complications (Laing et al.,
2003). In general, population with a low VO2max is consid-
ered to be at high risk of cardiac complications (Hooker et al.,
2008; Laukkanen et al., 2010). Although the background of this
association between low aerobic capacity and increased cardiac
risk is not fully understood, cardiovascular autonomic regu-
lation is one of the suggested mechanisms. This is based on
evidence of the associations between altered cardiac autonomic
regulation and cardiac complications, and between good car-
diorespiratory fitness and potentially cardioprotective parasym-
pathetic modulation of heart functions (Billman, 2002; Buch et al.,
2002).
Physical activity is known to benefit both the subjects in
increased risk of type 2 diabetes and the patients after onset of
the disease. The mechanisms are probably, at least partly, improve-
ments of insulin sensitivity and direct and/or indirect effects on
cardiovascular ANS function. However, the etiology and develop-
ment of type 2 diabetes and T1D are divergent, thus the study
results related to exercise training and aerobic capacity cannot be
generalized between these diseases. It remains to be seen in a longi-
tudinal study whether physical exercise training has similar effects
on VO2max and cardiovascular ANS function in T1D patients as
in type 2 diabetic or healthy populations (Buch et al., 2002; Carter
et al., 2003; Bassuk and Manson, 2005; Carnethon and Craft, 2008;
Hautala et al., 2009).
CONCLUSION
The increase in detrended fluctuation analysis variable alpha1 dur-
ing both active standing and the handgrip test was smaller in T1D
than in CON, which could indicate attenuated responsiveness of
sympathetic function in T1D relative to CON, although linear
HRV parameters could not show this. Instead, cardiovascular ANS
function at rest did not differ between T1D and CON. T1D patients
had lower VO2peak than healthy controls, although the groups
were matched based on their self-reported LTPA. Interestingly,
parasympathetic cardiac ANS variables at rest were associated
with VO2peak in CON, but not in T1D. The results suggest that
the DFA method and the alpha1 parameter in connection with
maneuvers, like active standing and handgrip, may be one of
the most sensitive indicators of early ANS function changes in
T1D.
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